Histological Subtype

Histological subtype refers to the category a tumor is placed in based on how its cells look under a microscope after a pathologist examines a tissue sample. For mesothelioma, the three main subtypes are epithelioid, sarcomatoid, and biphasic (a mix of both). The subtype strongly influences prognosis, treatment options, and how the cancer is likely to behave.

Origin

The term combines "histology", from the Greek histos (tissue) and logia (study of), coined by 19th-century German anatomist Karl Meyer, with "subtype," meaning a subdivision within a larger category. Histological classification of mesothelioma was formalized in the mid-20th century and is now standardized by the World Health Organization.

Significance in Asbestos Context

For someone diagnosed with mesothelioma, the histological subtype on the pathology report is one of the single most important pieces of information in the medical record. Epithelioid mesothelioma generally responds better to chemotherapy, immunotherapy, and surgery and carries a longer median survival; sarcomatoid is more aggressive and harder to treat; biphasic falls in between, with prognosis often tied to the percentage of each component. The subtype shapes which treatments doctors will offer, whether a patient may qualify for surgery or clinical trials, and how life expectancy is estimated, figures that can also affect the value of a legal claim and damages calculations for pain, suffering, and lost future earnings.

Example Sentence

When the oncologist reviewed the biopsy, she explained that the histological subtype was epithelioid, which meant her father was potentially eligible for a multimodal treatment plan including surgery.

Related Terms

Epithelioid Mesothelioma, Sarcomatoid Mesothelioma, Biphasic Mesothelioma, Immunohistochemistry, Pathology Report, Prognosis

Notes

• Request a copy of the full pathology report and confirm the subtype is clearly stated; if the report says "mesothelioma, NOS" (not otherwise specified), ask whether additional staining or a second opinion can refine the subtype.
• Consider getting a pathology second opinion from a mesothelioma specialty center (such as MD Anderson, Memorial Sloan Kettering, Brigham and Women's, or a university cancer center). Subtype misclassification isn't uncommon and can change treatment options.
• Preserve all pathology slides, blocks, and reports; these are critical both for ongoing medical decisions and for any legal claim, where experts may need to re-examine the tissue.
• Ask whether the report includes the percentage breakdown for biphasic tumors, since a higher epithelioid component generally predicts better outcomes.